NO20001937D0 - 2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D) - Google Patents

2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D)

Info

Publication number
NO20001937D0
NO20001937D0 NO20001937A NO20001937A NO20001937D0 NO 20001937 D0 NO20001937 D0 NO 20001937D0 NO 20001937 A NO20001937 A NO 20001937A NO 20001937 A NO20001937 A NO 20001937A NO 20001937 D0 NO20001937 D0 NO 20001937D0
Authority
NO
Norway
Prior art keywords
ht1d
ht1b
ht1a
substituted
serotonin antagonists
Prior art date
Application number
NO20001937A
Other languages
English (en)
Other versions
NO20001937L (no
Inventor
Wilfried Lubisch
Uta Dullweber
Dorothea Starck
Gerd Steiner
Alfred Bach
Franz Emling
Xavier Garcia-Ladona
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20001937D0 publication Critical patent/NO20001937D0/no
Publication of NO20001937L publication Critical patent/NO20001937L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20001937A 1997-10-22 2000-04-13 2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D) NO20001937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746612A DE19746612A1 (de) 1997-10-22 1997-10-22 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006300 WO1999020616A1 (de) 1997-10-22 1998-10-05 2-substituierte 1,2-benzisothiazol-derivate und ihre verwendung als serotonin-antagonisten (5-ht1a, 5-ht1b und 5-ht1d)

Publications (2)

Publication Number Publication Date
NO20001937D0 true NO20001937D0 (no) 2000-04-13
NO20001937L NO20001937L (no) 2000-04-13

Family

ID=7846266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001937A NO20001937L (no) 1997-10-22 2000-04-13 2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D)

Country Status (23)

Country Link
US (1) US6346622B1 (no)
EP (1) EP1034170A1 (no)
JP (1) JP2001520224A (no)
KR (1) KR20010031297A (no)
CN (1) CN1277607A (no)
AR (1) AR016968A1 (no)
AU (1) AU748613B2 (no)
BG (1) BG104332A (no)
BR (1) BR9812948A (no)
CA (1) CA2307199A1 (no)
CO (1) CO4980863A1 (no)
DE (1) DE19746612A1 (no)
HR (1) HRP980555A2 (no)
HU (1) HUP0003758A3 (no)
IL (1) IL135256A0 (no)
NO (1) NO20001937L (no)
NZ (1) NZ503604A (no)
PL (1) PL340033A1 (no)
SK (1) SK4572000A3 (no)
TR (1) TR200001080T2 (no)
TW (1) TW517052B (no)
WO (1) WO1999020616A1 (no)
ZA (1) ZA989571B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
JP2006503106A (ja) * 2002-09-17 2006-01-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 統合失調症を処置するためのヘテロ環式置換ピペラジン
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
DE60334016D1 (de) 2002-11-05 2010-10-14 Glaxo Group Ltd Antibakterielle mittel
KR100472988B1 (ko) 2002-11-27 2005-03-10 씨제이 주식회사 조직감, 취반성 및 안전성이 우수한 발아 현미의 제조방법및 이로부터 얻은 발아 현미
CN101151249B (zh) * 2005-03-31 2011-04-06 辉瑞产品公司 环戊吡啶及四氢喹啉衍生物
KR101682058B1 (ko) * 2008-12-11 2016-12-02 비이브 헬쓰케어 컴퍼니 카르바모일피리돈 ｈｉｖ 인테그라제 억제제를 위한 제조방법 및 중간체
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
NL8601494A (nl) 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体

Also Published As

Publication number Publication date
PL340033A1 (en) 2001-01-15
BR9812948A (pt) 2000-08-08
AR016968A1 (es) 2001-08-01
BG104332A (en) 2001-02-28
WO1999020616A1 (de) 1999-04-29
CO4980863A1 (es) 2000-11-27
KR20010031297A (ko) 2001-04-16
CN1277607A (zh) 2000-12-20
EP1034170A1 (en) 2000-09-13
TW517052B (en) 2003-01-11
US6346622B1 (en) 2002-02-12
NZ503604A (en) 2002-03-01
AU1149799A (en) 1999-05-10
HRP980555A2 (en) 1999-08-31
ZA989571B (en) 2000-04-25
NO20001937L (no) 2000-04-13
IL135256A0 (en) 2001-05-20
TR200001080T2 (tr) 2001-01-22
AU748613B2 (en) 2002-06-06
JP2001520224A (ja) 2001-10-30
SK4572000A3 (en) 2000-10-09
CA2307199A1 (en) 1999-04-29
HUP0003758A3 (en) 2001-12-28
DE19746612A1 (de) 1999-04-29
HUP0003758A1 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
NO20032503L (no) Fenyletenyl- eller fenyletynylderivater som glutamatreseptorantagonister
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
NO990551D0 (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
IS4813A (is) Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka
DE69907964D1 (de) 1,2-annelierte chinolinderivate
NO20021459L (no) Piperazin-derivater som 5-HT1B-antagonister
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20042372L (no) Nye 1,2,4-tiadiazolderivater som melanokortinreseptormodulatorer
NO985193D0 (no) Mesylat-trihydrat av 5-(2-(4-(1,2-benzoisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on(=ziperasidone), fremstilling derav og anvendelse derav som dopamin-D2-antagonist
NO20043064L (no) 1-alkyl-1-azoniabisyklo [2.2.2] oktankarbamatderivater og anvendelse av disse som muskarine reseptorantagonister
DE60234409D1 (de) Säuregenerator, Sulfonsäure, Sulfonsäurederivate und strahlungsempfindliche Zusammensetzung
NO20000185L (no) Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse
NO20011350D0 (no) 4-Karboksyaminosubstituerte 1,2,3,4-tetrahydrokinoliner som CETP inhibitorer
EE200000640A (et) Uus kasutamine
DK1296976T3 (da) 1,3-dihydro-2H-indol-2-on-derivater og deres anvendelse som lagander for ariginin-vasopressin-receptorerne V1B og V1A
NO20006138D0 (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
EE05386B1 (et) Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim
DK1445249T3 (da) Nye bensophenon-derivater eller salte deraf
NO20006460D0 (no) 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse
NO20003451D0 (no) 2,3-substituerte indolforbindelser som cox-2 inhibitorer
FI962969A0 (fi) Indolijohdannaisia 5-HT1:n agonisteina
DK0839146T3 (da) Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
ATE266637T1 (de) 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
NO20004271D0 (no) Benzylpiperazinyl- og benzylpiperidinyl etanonderivater, deres fremstilling og deres anvendelse som dopamin D4 reseptorantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application